Technical Analysis for COGT - Cogent Biosciences, Inc.

Grade Last Price % Change Price Change
D 8.71 0.35% 0.03
COGT closed up 0.35 percent on Thursday, April 22, 2021, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical COGT trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Crossed Above 20 DMA Bullish 0.35%
Crossed Above 50 DMA Bullish 0.35%
Bollinger Band Squeeze Range Contraction 0.35%
Bollinger Band Squeeze Range Contraction 3.08%
Hammer Candlestick Bullish 4.94%
Older End-of-Day Signals for COGT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 6 hours ago
20 DMA Support about 10 hours ago
10 DMA Support about 10 hours ago
Down 1% about 10 hours ago
Fell Below 50 DMA about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases. Cogent's most advanced program, PLX9486, is a highly selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Cogent is headquartered in Cambridge, MA.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Clinical Medicine Diseases Gastrointestinal Enzymes Tyrosine Kinase Protein Kinase Inhibitor Gastrointestinal Stromal Tumor Mastocytosis Systemic Mastocytosis Gastrointestinal Stromal Tumors Imatinib

Is COGT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.88
52 Week Low 1.48
Average Volume 391,290
200-Day Moving Average 10.32
50-Day Moving Average 8.64
20-Day Moving Average 8.61
10-Day Moving Average 8.61
Average True Range 0.53
ADX 11.51
+DI 23.15
-DI 20.96
Chandelier Exit (Long, 3 ATRs ) 7.86
Chandelier Exit (Short, 3 ATRs ) 9.52
Upper Bollinger Band 9.17
Lower Bollinger Band 8.04
Percent B (%b) 0.59
BandWidth 13.08
MACD Line -0.04
MACD Signal Line -0.05
MACD Histogram 0.0196
Fundamentals Value
Market Cap 169.04 Million
Num Shares 19.4 Million
EPS
Price-to-Sales 3.49
Price-to-Book 6.51
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.19
Resistance 3 (R3) 9.20 9.04 9.11
Resistance 2 (R2) 9.04 8.92 9.04 9.08
Resistance 1 (R1) 8.88 8.85 8.96 8.87 9.06
Pivot Point 8.72 8.72 8.77 8.72 8.72
Support 1 (S1) 8.56 8.60 8.64 8.55 8.36
Support 2 (S2) 8.40 8.53 8.40 8.34
Support 3 (S3) 8.24 8.40 8.31
Support 4 (S4) 8.23